Lanzamiento Enero 2027

Ensayo controlado aleatorizado2018

Intermittent fasting in Type 2 diabetes mellitus and the risk of hypoglycaemia: a randomized controlled trial

Corley BT, Carroll RW, Hall RM, Weatherall M, Parry-Strong A, Krebs JD

Diabetic medicine : a journal of the British Diabetic Association · 134 citas

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento

Quién lo pagó

Financiación
Financiación independiente
Organización sin fines de lucro
New Zealand Society for the Study of Diabetes

Según 1 financiador declarado.

Publicación

Publicado
2018-02-06 · Diabet Med · vol. 35 · número 5 · págs. 588–594
Editorial
Wiley
Citado
219 citas · más que el 99% de estudios similares · 9.5× el promedio de su campo
Impacto
Entre el 10 % más citado de su campo
Referencias
21 trabajos
Acceso
De pago
Áreas de investigación
Dietary Effects on Health · Diet and metabolism studies · Diabetes Management and Research
Palabras clave
Medicine, Internal medicine, Diabetes mellitus, Randomized controlled trial, Type 2 diabetes, Hypoglycemia, Weight loss, Intermittent fasting, Metformin, Calorie, Gastroenterology, Endocrinology, Obesity
MeSH
humans, diabetes mellitus, type 2, hypoglycemia, obesity, body weight, blood glucose, hypoglycemic agents, caloric restriction, fasting, quality of life, adult, aged, middle aged, female, male, glycated hemoglobin

6 autores

  • Brian Corley🇳🇿 · autor de correspondenciaWellington Hospital; University of Otago
  • Richard W. Carroll🇳🇿Wellington Hospital; University of Otago
  • Rosemary M. Hall🇳🇿Wellington Hospital; University of Otago
  • Mark W Weatherall🇳🇿University of Otago
  • Amber Parry‐Strong🇳🇿Wellington Hospital
  • Jeremy Krebs🇳🇿Wellington Hospital; University of Otago

Resumen

El texto original del estudio, en el idioma en que se publicó.

Aims

To establish whether the risk of hypoglycaemia is greater with 2 consecutive days of very-low-calorie diet compared with 2 non-consecutive days of very-low-calorie diet in people with Type 2 diabetes.

Methods

This was a non-blinded randomized parallel group interventional trial of intermittent fasting in adults. The participants had a BMI of 30-45 kg/m2 , Type 2 diabetes treated with metformin and/or hypoglycaemic medications and an HbA1c concentration of 50-86 mmol/mol (6.7-10%). The participants followed a 2092-2510-kJ diet on 2 days per week for 12 weeks. A total of 41 participants were randomized 1:1 to consecutive (n=19) or non-consecutive (n=22) day fasts, of whom 37 (n=18 and n=19, respectively) were included in the final analysis. The primary outcome was difference in the rate of hypoglycaemia between the two study arms. Secondary outcomes included change in diet, quality of life, weight, lipid, glucose and HbA1c levels, and liver function.

Results

The mean hypoglycaemia rate was 1.4 events over 12 weeks. Fasting increased the rate of hypoglycaemia despite medication reduction (RR 2.05, 95% CI 1.17 to 3.52). There was no difference between fasting on consecutive days and fasting on non-consecutive days (RR 1.54, 95% CI 0.35 to 6.11). Improvements in weight, HbA1c , fasting glucose and quality of life were experienced by participants in both arms.

Conclusions

In individuals with Type 2 diabetes on hypoglycaemic medications, fasting of any type increased the rate of hypoglycaemia. With education and medication reduction, fewer than expected hypoglycaemic events occurred. Although it was not possible to determine whether fasting on consecutive days increased the risk of hypoglycaemia, an acceptable rate was observed in both arms.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.